Novel germline CDK4 mutations in patients with head and neck cancer

Maimoona Sabir1, Ruqia Mehmood Baig, Ishrat Mahjabeen

  • 1Cancer Genetics Lab, Department of Biosciences, COMSATS Institute of Information Technology, Park Road Chak shahzad, Islamabad, Pakistan. mkayani@comsats.edu.pk.

Abstract

Insights

Cyclin-dependent kinase 4 (CDK4) mutations were investigated in head and neck cancers. Novel mutations in CDK4 were identified, suggesting a role in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cyclin-dependent kinase 4 (CDK4) and cyclin D1 regulate cell cycle progression.
  • The p16/CDK4/cyclin D1 complex is frequently deregulated in various human cancers.
  • CDK4 alterations are infrequently observed in tumors.

Purpose of the Study:

  • To screen for germline mutations in the coding regions of CDK4.
  • To investigate the role of CDK4 mutations in squamous cell carcinoma of the head and neck.

Main Methods:

  • PCR-SSCP and direct sequencing were employed for mutational screening of CDK4.
  • DNA was isolated from peripheral blood leukocytes of patients with head and neck squamous cell carcinoma.

Main Results:

  • Three missense mutations (Ser52Thr, Glu67Gln, Pro194Ser) and three novel frameshift mutations were identified in CDK4.
  • Mutations were observed in exon 2, exon 5, exon 7, and the 3'UTR of CDK4.
  • Two novel mutations were found in the N-terminal domain of CDK4.

Conclusions:

  • CDK4 mutations may play a significant role in the development and progression of head and neck squamous cell carcinoma.
  • The identified novel mutations provide further insight into CDK4's involvement in cancer.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...